Koninklijke Philips N.V. (PHG)
USD 24.71
(-1.2%)
USD 24.71
(-1.2%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.34 Billion EUR | -0.34% |
| 2022 | 17.4 Billion EUR | 5.57% |
| 2021 | 16.48 Billion EUR | 4.27% |
| 2020 | 15.81 Billion EUR | 10.13% |
| 2019 | 14.35 Billion EUR | 3.28% |
| 2018 | 13.9 Billion EUR | 4.59% |
| 2017 | 13.29 Billion EUR | -29.28% |
| 2016 | 18.79 Billion EUR | -2.09% |
| 2015 | 19.19 Billion EUR | 10.42% |
| 2014 | 17.38 Billion EUR | 13.38% |
| 2013 | 15.33 Billion EUR | -14.37% |
| 2012 | 17.9 Billion EUR | 8.01% |
| 2011 | 16.57 Billion EUR | -3.49% |
| 2010 | 17.17 Billion EUR | 8.15% |
| 2009 | 15.88 Billion EUR | -1.94% |
| 2008 | 16.19 Billion EUR | 10.64% |
| 2007 | 14.63 Billion EUR | -4.74% |
| 2006 | 15.36 Billion EUR | -8.79% |
| 2005 | 16.84 Billion EUR | 8.23% |
| 2004 | 15.56 Billion EUR | -2.9% |
| 2003 | 16.03 Billion EUR | -11.94% |
| 2002 | 18.2 Billion EUR | -8.2% |
| 2001 | 19.83 Billion EUR | 21.08% |
| 2000 | 16.38 Billion EUR | 13.38% |
| 1999 | 14.44 Billion EUR | 5.97% |
| 1998 | 13.63 Billion EUR | -19.16% |
| 1997 | 16.86 Billion EUR | -7.68% |
| 1996 | 18.26 Billion EUR | -1.44% |
| 1995 | 18.53 Billion EUR | 17.11% |
| 1994 | 15.82 Billion EUR | 3.24% |
| 1993 | 15.32 Billion EUR | -15.28% |
| 1992 | 18.09 Billion EUR | 12.98% |
| 1991 | 16.01 Billion EUR | -3.59% |
| 1990 | 16.61 Billion EUR | 4.88% |
| 1989 | 15.83 Billion EUR | 2.28% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 17.55 Billion EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q4 | 17.34 Billion EUR | 0.0% |
| 2023 Q2 | 17.34 Billion EUR | 6.09% |
| 2023 Q1 | 16.35 Billion USD | -6.06% |
| 2023 FY | 17.34 Billion EUR | -0.34% |
| 2022 Q2 | 17.72 Billion EUR | 0.0% |
| 2022 Q4 | 17.4 Billion EUR | 0.0% |
| 2022 FY | 17.4 Billion EUR | 5.57% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 Q2 | 17.02 Billion EUR | 0.0% |
| 2021 Q4 | 16.48 Billion EUR | 0.0% |
| 2021 FY | 16.48 Billion EUR | 4.27% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2020 Q2 | 16.5 Billion EUR | 0.0% |
| 2020 Q4 | 15.81 Billion EUR | 0.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 15.81 Billion EUR | 10.13% |
| 2020 Q3 | - EUR | -100.0% |
| 2019 Q4 | 14.35 Billion EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 14.42 Billion EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 FY | 14.35 Billion EUR | 3.28% |
| 2018 Q2 | 13.12 Billion EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q4 | 13.9 Billion EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 FY | 13.9 Billion EUR | 4.59% |
| 2017 Q4 | 13.29 Billion EUR | -24.93% |
| 2017 FY | 13.29 Billion EUR | -29.28% |
| 2017 Q1 | 17.83 Billion EUR | -5.11% |
| 2017 Q2 | 15.68 Billion EUR | -12.07% |
| 2017 Q3 | 17.7 Billion EUR | 12.91% |
| 2016 Q3 | 18.43 Billion EUR | -1.64% |
| 2016 Q1 | 18.34 Billion EUR | -4.42% |
| 2016 Q2 | 18.74 Billion EUR | 2.16% |
| 2016 Q4 | 18.79 Billion EUR | 1.94% |
| 2016 FY | 18.79 Billion EUR | -2.09% |
| 2015 Q3 | 18.63 Billion EUR | -3.82% |
| 2015 Q1 | 20.29 Billion EUR | 16.76% |
| 2015 Q4 | 19.19 Billion EUR | 3.01% |
| 2015 FY | 19.19 Billion EUR | 10.42% |
| 2015 Q2 | 19.37 Billion EUR | -4.54% |
| 2014 Q1 | 14.94 Billion EUR | -2.5% |
| 2014 Q4 | 17.38 Billion EUR | 2.75% |
| 2014 Q3 | 16.91 Billion EUR | 13.54% |
| 2014 Q2 | 14.9 Billion EUR | -0.32% |
| 2014 FY | 17.38 Billion EUR | 13.38% |
| 2013 Q1 | 17.52 Billion EUR | -2.1% |
| 2013 FY | 15.33 Billion EUR | -14.37% |
| 2013 Q2 | 16.82 Billion EUR | -4.03% |
| 2013 Q4 | 15.33 Billion EUR | -6.36% |
| 2013 Q3 | 16.37 Billion EUR | -2.67% |
| 2012 Q1 | 17.34 Billion EUR | 4.65% |
| 2012 Q2 | 17.03 Billion EUR | -1.82% |
| 2012 FY | 17.9 Billion EUR | 8.01% |
| 2012 Q4 | 17.9 Billion EUR | 5.35% |
| 2012 Q3 | 16.99 Billion EUR | -0.21% |
| 2011 Q1 | 15.85 Billion EUR | -7.73% |
| 2011 FY | 16.57 Billion EUR | -3.49% |
| 2011 Q3 | 14.77 Billion EUR | 5.33% |
| 2011 Q4 | 16.57 Billion EUR | 12.22% |
| 2011 Q2 | 14.02 Billion EUR | -11.52% |
| 2010 Q2 | 18.51 Billion EUR | 7.61% |
| 2010 FY | 17.17 Billion EUR | 8.15% |
| 2010 Q1 | 17.2 Billion EUR | 8.34% |
| 2010 Q4 | 17.17 Billion EUR | 3.36% |
| 2010 Q3 | 16.61 Billion EUR | -10.26% |
| 2009 Q3 | 15.97 Billion EUR | 1.94% |
| 2009 Q4 | 15.88 Billion EUR | -0.59% |
| 2009 Q2 | 15.67 Billion EUR | -5.34% |
| 2009 Q1 | 16.55 Billion EUR | -1.16% |
| 2009 FY | 15.88 Billion EUR | -1.94% |
| 2008 Q2 | 14.98 Billion EUR | -15.16% |
| 2008 FY | 16.19 Billion EUR | 10.64% |
| 2008 Q1 | 17.66 Billion EUR | 20.67% |
| 2008 Q3 | 15.87 Billion EUR | 5.95% |
| 2008 Q4 | 16.75 Billion EUR | 5.49% |
| 2007 Q4 | 14.63 Billion EUR | 0.95% |
| 2007 Q3 | 14.5 Billion EUR | 1.17% |
| 2007 FY | 14.63 Billion EUR | -4.74% |
| 2007 Q1 | 15.23 Billion EUR | -0.9% |
| 2007 Q2 | 14.33 Billion EUR | -5.88% |
| 2006 Q4 | 15.36 Billion EUR | -0.31% |
| 2006 Q3 | 15.41 Billion EUR | -3.27% |
| 2006 Q1 | 17 Billion EUR | 0.94% |
| 2006 FY | 15.36 Billion EUR | -8.79% |
| 2006 Q2 | 15.93 Billion EUR | -6.29% |
| 2005 Q1 | 15.52 Billion EUR | -0.28% |
| 2005 FY | 16.84 Billion EUR | 8.23% |
| 2005 Q4 | 16.84 Billion EUR | 5.91% |
| 2005 Q3 | 15.9 Billion EUR | 4.15% |
| 2005 Q2 | 15.27 Billion EUR | -1.61% |
| 2004 Q4 | 15.56 Billion EUR | -1.63% |
| 2004 FY | 15.56 Billion EUR | -2.9% |
| 2004 Q1 | 17.44 Billion EUR | 8.77% |
| 2004 Q2 | 16.75 Billion EUR | -3.93% |
| 2004 Q3 | 15.82 Billion EUR | -5.54% |
| 2003 Q4 | 16.03 Billion EUR | -6.06% |
| 2003 FY | 16.03 Billion EUR | -11.94% |
| 2003 Q3 | 17.06 Billion EUR | -0.58% |
| 2003 Q2 | 17.16 Billion EUR | -5.98% |
| 2003 Q1 | 18.25 Billion EUR | 0.28% |
| 2002 FY | 18.2 Billion EUR | -8.2% |
| 2002 Q1 | 20.24 Billion EUR | 2.06% |
| 2002 Q2 | 18.79 Billion EUR | -7.17% |
| 2002 Q3 | 19.17 Billion EUR | 2.02% |
| 2002 Q4 | 18.2 Billion EUR | -5.02% |
| 2001 FY | 19.83 Billion EUR | 21.08% |
| 2001 Q2 | 17.72 Billion EUR | 1.73% |
| 2001 Q1 | 17.42 Billion EUR | 6.36% |
| 2001 Q3 | 19.74 Billion EUR | 11.42% |
| 2001 Q4 | 19.83 Billion EUR | 0.43% |
| 2000 Q1 | 15.13 Billion EUR | 4.79% |
| 2000 FY | 16.38 Billion EUR | 13.38% |
| 2000 Q2 | 15.09 Billion EUR | -0.3% |
| 2000 Q3 | 16.49 Billion EUR | 9.28% |
| 2000 Q4 | 16.38 Billion EUR | -0.7% |
| 1999 FY | 14.44 Billion EUR | 5.97% |
| 1999 Q2 | 13.47 Billion EUR | -0.84% |
| 1999 Q1 | 13.58 Billion EUR | -0.33% |
| 1999 Q3 | 13.63 Billion EUR | 1.21% |
| 1999 Q4 | 14.44 Billion EUR | 5.94% |
| 1998 Q1 | 16.78 Billion EUR | -0.45% |
| 1998 FY | 13.63 Billion EUR | -19.16% |
| 1998 Q4 | 13.63 Billion EUR | 2.83% |
| 1998 Q3 | 13.25 Billion EUR | -1.13% |
| 1998 Q2 | 13.4 Billion EUR | -20.12% |
| 1997 Q1 | 19.05 Billion EUR | 4.34% |
| 1997 FY | 16.86 Billion EUR | -7.68% |
| 1997 Q4 | 16.86 Billion EUR | -10.97% |
| 1997 Q3 | 18.94 Billion EUR | 0.39% |
| 1997 Q2 | 18.86 Billion EUR | -1.0% |
| 1996 Q4 | 18.26 Billion EUR | 0.0% |
| 1996 FY | 18.26 Billion EUR | -1.44% |
| 1995 FY | 18.53 Billion EUR | 17.11% |
| 1995 Q4 | 18.53 Billion EUR | 0.0% |
| 1994 Q4 | 15.82 Billion EUR | 0.0% |
| 1994 FY | 15.82 Billion EUR | 3.24% |
| 1993 Q4 | 15.32 Billion EUR | 0.0% |
| 1993 FY | 15.32 Billion EUR | -15.28% |
| 1992 Q4 | 18.09 Billion EUR | 0.0% |
| 1992 FY | 18.09 Billion EUR | 12.98% |
| 1991 FY | 16.01 Billion EUR | -3.59% |
| 1991 Q4 | 16.01 Billion EUR | 0.0% |
| 1990 Q4 | 16.61 Billion EUR | 0.0% |
| 1990 FY | 16.61 Billion EUR | 4.88% |
| 1989 Q4 | 15.83 Billion EUR | 0.0% |
| 1989 FY | 15.83 Billion EUR | 2.28% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott Laboratories | 34.38 Billion USD | 49.559% |
| Allurion Technologies Inc. | 142.19 Million USD | -12097.695% |
| Artivion, Inc. | 510.61 Million USD | -3296.871% |
| Avanos Medical, Inc. | 456.1 Million USD | -3702.894% |
| Butterfly Network, Inc. | 84.22 Million USD | -20494.626% |
| Butterfly Network, Inc. | 84.22 Million USD | -20494.626% |
| Bio-Rad Laboratories, Inc. | 3.55 Billion USD | -387.502% |
| Boston Scientific Corporation | 15.6 Billion USD | -11.143% |
| Perspective Therapeutics, Inc. | 3.44 Million USD | -502799.391% |
| CONMED Corporation | 1.46 Billion USD | -1083.314% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | -556.063% |
| Paragon 28, Inc. | 162.95 Million USD | -10543.847% |
| Glaukos Corporation | 478.64 Million USD | -3523.749% |
| Globus Medical, Inc. | 1.08 Billion USD | -1494.028% |
| Inspire Medical Systems, Inc. | 104.29 Million USD | -16530.392% |
| Integer Holdings Corporation | 1.41 Billion USD | -1127.336% |
| Medtronic plc | 39.56 Billion USD | 56.156% |
| Nevro Corp. | 330.31 Million USD | -5151.112% |
| Owlet, Inc. | 73.79 Million USD | -23403.028% |
| Penumbra, Inc. | 377.36 Million USD | -4496.394% |
| Vicarious Surgical Inc. | 21.89 Million USD | -79119.0% |
| Smith & Nephew plc | 4.77 Billion USD | -263.627% |
| Sonendo, Inc. | 49.74 Million USD | -34770.63% |
| STERIS plc | 4.74 Billion USD | -265.285% |
| Stryker Corporation | 21.31 Billion USD | 18.641% |
| Vapotherm, Inc. | 132.95 Million USD | -12946.16% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | -92.536% |